• Therapeutic use and toxicity of high-dose methotrexate
  View in Chinese
  • Summary and recommendations
• Major side effects of low-dose methotrexate
  • Summary and recommendations
• Methotrexate-induced lung injury
  View in Chinese
  • Clinical manifestations
  • Summary and recommendations
• Crystal-induced acute kidney injury (acute renal failure)
  View in Chinese
  • Methotrexate
  • Summary and recommendations
• Dosing of anticancer agents in adults
  View in Chinese
  • Summary and recommendations
• Overview of immunosuppressive agents used for prevention and treatment of graft-versus-host disease
  View in Chinese
  • Toxicities and clinical use
  • Summary
• Hepatotoxicity associated with chronic low-dose methotrexate for nonmalignant disease
  View in Chinese
  • Summary and recommendations
• Use of methotrexate in the treatment of rheumatoid arthritis
  View in Chinese
  • Summary and recommendations
• Prevention of acute graft-versus-host disease
  View in Chinese
  • Calcineurin inhibitor-based therapy
  • Summary and recommendations
• Pulmonary complications of inflammatory bowel disease
  View in Chinese
  • Methotrexate
  • Summary and recommendations
• Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency
  View in Chinese
  • Methotrexate
  • Summary and recommendations
• Overview of neurologic complications of non-platinum cancer chemotherapy
  View in Chinese
  • Summary
• Overview of the treatment of primary biliary cholangitis (primary biliary cirrhosis)
  View in Chinese
  • Summary and recommendations
• Society guideline links: Psoriatic juvenile idiopathic arthritis
• Polyarticular juvenile idiopathic arthritis: Treatment
  View in Chinese
  • Monitoring on DMARD therapy
  • Folic acid
  • Summary and recommendations
• Maintenance immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis
  View in Chinese
  • Methotrexate dosing
  • Choosing a maintenance drug
  • Summary and recommendations
• Initial management of cutaneous dermatomyositis
  View in Chinese
  • Second-line systemic therapy
  • Summary and recommendations
• Primary cutaneous anaplastic large cell lymphoma
  View in Chinese
  • Summary and recommendations
• Pustular psoriasis: Management
  View in Chinese
  • Summary and recommendations
• Initial treatment of dermatomyositis and polymyositis in adults
  View in Chinese
  • Adverse effects
  • Summary and recommendations
• Treatment of large granular lymphocyte leukemia
  View in Chinese
  • Summary and recommendations
• Management of cutaneous sarcoidosis
  View in Chinese
  • Methotrexate
  • Summary and recommendations
• Systemic lupus erythematosus (SLE) in children: Treatment, complications, and prognosis
  View in Chinese
  • Moderate SLE
  • Summary and recommendations
• Systemic juvenile idiopathic arthritis: Treatment
  View in Chinese
  • Summary and recommendations
• Juvenile dermatomyositis and polymyositis: Treatment, complications, and prognosis
  View in Chinese
  • Mild to moderate disease
  • Summary and recommendations
• Management of refractory discoid lupus and subacute cutaneous lupus
  • Summary and recommendations
• Erythrodermic psoriasis in adults
  • Summary and recommendations
• Treatment, prognosis, and prophylaxis of secondary central nervous system lymphoma
  View in Chinese
  • Summary and recommendations
• Treatment and prognosis of polyarteritis nodosa
  View in Chinese
  • Summary and recommendations
• Drug-induced lung disease in rheumatoid arthritis
  • Summary and recommendations
• Treatment of retroperitoneal fibrosis
  View in Chinese
  • Summary and recommendations
• Induction therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults
  View in Chinese
  • Patients with Down syndrome
  • Summary and recommendations
• Treatment of scleritis
  View in Chinese
  • Summary and recommendations
• Fertility, pregnancy, and nursing in inflammatory bowel disease
  View in Chinese
  • Summary and recommendations
• Initial immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis
  View in Chinese
  • Summary and recommendations
• Lymphomatoid papulosis
  View in Chinese
  • Summary and recommendations
• Treatment of psoriasis
  View in Chinese
  • Summary and recommendations
• Chronic beryllium disease (berylliosis)
  View in Chinese
  • Other immunosuppressive agents
  • Summary and recommendations
• Desmoid tumors: Systemic therapy
  • Summary and recommendations
• Treatment of advanced stage (IIB to IV) mycosis fungoides
  View in Chinese
  • Summary and recommendations
• Diagnosis and treatment of vasculitic neuropathy
  View in Chinese
  • Summary and recommendations
• Hematologic manifestations of rheumatoid arthritis
  View in Chinese
  • Summary and recommendations
• Cogan’s syndrome
  View in Chinese
  • Summary and recommendations
• Interstitial lung disease in rheumatoid arthritis
  View in Chinese
  • Summary and recommendations
• Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis
  View in Chinese
  • Summary and recommendations
• Mitomycin-C pulmonary toxicity
  • Summary and recommendations
• Treatment of Sézary syndrome
  View in Chinese
  • Summary and recommendations
• Treatment of progressive multiple sclerosis in adults
  View in Chinese
  • Summary and recommendations
• Gastrointestinal and hepatic sarcoidosis
  View in Chinese
  • Summary and recommendations
• Comorbid disease in psoriasis
  • Summary and recommendations

Topic Outline Hide Topic Outline Show Graphics (0)